IM Cannabis (NASDAQ:IMCC – Get Free Report) and Senestech (NASDAQ:SNES – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.
Insider and Institutional Ownership
7.7% of IM Cannabis shares are owned by institutional investors. Comparatively, 5.2% of Senestech shares are owned by institutional investors. 5.9% of IM Cannabis shares are owned by company insiders. Comparatively, 2.2% of Senestech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares IM Cannabis and Senestech”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IM Cannabis | $39.17 million | 0.03 | -$8.10 million | ($1.75) | -0.12 |
| Senestech | $2.22 million | 3.87 | -$6.38 million | ($1.89) | -0.86 |
Senestech has lower revenue, but higher earnings than IM Cannabis. Senestech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
IM Cannabis has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500. Comparatively, Senestech has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500.
Profitability
This table compares IM Cannabis and Senestech’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IM Cannabis | -27.65% | -585.96% | -39.96% |
| Senestech | -304.22% | -67.60% | -49.21% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for IM Cannabis and Senestech, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IM Cannabis | 1 | 0 | 0 | 0 | 1.00 |
| Senestech | 1 | 1 | 0 | 1 | 2.33 |
Summary
IM Cannabis beats Senestech on 8 of the 13 factors compared between the two stocks.
About IM Cannabis
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
About Senestech
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
